ICU Medical, Inc. (ICUI)
156.48
-0.78
(-0.50%)
USD |
NASDAQ |
Sep 11, 16:00
156.51
+0.03
(+0.02%)
After-Hours: 20:00
ICU Medical Enterprise Value : 4.902B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.902B |
| September 10, 2026 | 4.921B |
| September 09, 2026 | 5.015B |
| September 08, 2026 | 5.012B |
| September 04, 2026 | 5.180B |
| September 03, 2026 | 5.147B |
| September 02, 2026 | 5.236B |
| September 01, 2026 | 5.260B |
| August 31, 2026 | 5.314B |
| August 28, 2026 | 5.368B |
| August 27, 2026 | 5.368B |
| August 26, 2026 | 5.480B |
| August 25, 2026 | 5.546B |
| August 24, 2026 | 5.554B |
| August 21, 2026 | 5.561B |
| August 20, 2026 | 5.553B |
| August 19, 2026 | 5.672B |
| August 18, 2026 | 5.584B |
| August 17, 2026 | 5.553B |
| August 14, 2026 | 5.565B |
| August 13, 2026 | 5.568B |
| August 12, 2026 | 5.474B |
| August 11, 2026 | 5.542B |
| August 10, 2026 | 5.551B |
| August 07, 2026 | 5.604B |
| Date | Value |
|---|---|
| August 06, 2026 | 5.149B |
| August 05, 2026 | 5.150B |
| August 04, 2026 | 5.289B |
| August 03, 2026 | 5.314B |
| July 31, 2026 | 5.203B |
| July 30, 2026 | 5.200B |
| July 29, 2026 | 5.153B |
| July 28, 2026 | 5.134B |
| July 27, 2026 | 5.026B |
| July 24, 2026 | 4.926B |
| July 23, 2026 | 4.826B |
| July 22, 2026 | 4.926B |
| July 21, 2026 | 4.959B |
| July 20, 2026 | 4.923B |
| July 17, 2026 | 4.928B |
| July 16, 2026 | 5.044B |
| July 15, 2026 | 4.939B |
| July 14, 2026 | 4.827B |
| July 13, 2026 | 4.930B |
| July 10, 2026 | 4.850B |
| July 09, 2026 | 4.903B |
| July 08, 2026 | 4.787B |
| July 07, 2026 | 4.874B |
| July 06, 2026 | 4.976B |
| July 02, 2026 | 4.864B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Baxter International, Inc. | 18.98B |
| Becton, Dickinson & Co. | 64.39B |
| Boston Scientific Corp. | 74.40B |
| Glaukos Corp. | 9.661B |
| Medline, Inc. | 45.99B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 19.09M |
| Revenue (Quarterly) | 552.19M |
| Total Expenses (Quarterly) | 533.10M |
| EPS Diluted (Quarterly) | 0.7621 |
| Gross Profit Margin (Quarterly) | 36.74% |
| Profit Margin (Quarterly) | 3.46% |
| Earnings Yield | 0.76% |
| Operating Earnings Yield | 3.70% |
| Normalized Earnings Yield | 2.044 |